Global Untargeted Metabolomics Market Research Report 2026(Status and Outlook)
Untargeted metabolomics is a study in which all detectable metabolites are identified and quantitated for analyzing the overall metabolic characteristics and discovering metabolic mechanisms behind the phenomenon. Also known as discovery metabolomics, untargeted metabolomics is a powerful tool for large-scale early phase diagnosis and discovery of new biomarkers. Compared to traditional metabolic quantitation methods, untargeted metabolomics is a high-throughput technology, enabling more comprehensive analysis with more accurate data acquisition, eliminating biased research direction.
The global Untargeted Metabolomics market size was estimated at USD 1522.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Untargeted Metabolomics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Untargeted Metabolomics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Untargeted Metabolomics market.
Global Untargeted Metabolomics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Dynamics Inc (Creative Proteomics)
Metabolon
Alfa Chemistry
Novelgene Technologies
MtoZ-Biolabs Inc.
CD Genomics
Metware Biotechnology Inc (Metware)
BGI Genomics
APPLIED PROTEIN TECHNOLOGY
Suzhou PANOMIX Biomedical Tech Co.,Ltd
OBiO Technology ( Shanghai ) Corp.,Ltd.
Beijing Huayi innovation & BioTechnology Co., Ltd
Abace Biotechnology
Metabo-Profile
Market Segmentation (by Type)
Plant Untargeted Metabolomics
Human Untargeted Metabolomics
Other
Market Segmentation (by Application)
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Untargeted Metabolomics Market
Overview of the regional outlook of the Untargeted Metabolomics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Untargeted Metabolomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Untargeted Metabolomics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Untargeted Metabolomics market size was estimated at USD 1522.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Untargeted Metabolomics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Untargeted Metabolomics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Untargeted Metabolomics market.
Global Untargeted Metabolomics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Dynamics Inc (Creative Proteomics)
Metabolon
Alfa Chemistry
Novelgene Technologies
MtoZ-Biolabs Inc.
CD Genomics
Metware Biotechnology Inc (Metware)
BGI Genomics
APPLIED PROTEIN TECHNOLOGY
Suzhou PANOMIX Biomedical Tech Co.,Ltd
OBiO Technology ( Shanghai ) Corp.,Ltd.
Beijing Huayi innovation & BioTechnology Co., Ltd
Abace Biotechnology
Metabo-Profile
Market Segmentation (by Type)
Plant Untargeted Metabolomics
Human Untargeted Metabolomics
Other
Market Segmentation (by Application)
Academic and Research Institutions
Pharmaceutical and Biotechnology Companies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Untargeted Metabolomics Market
Overview of the regional outlook of the Untargeted Metabolomics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Untargeted Metabolomics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Untargeted Metabolomics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Untargeted Metabolomics
1.2 Key Market Segments
1.2.1 Untargeted Metabolomics Segment by Type
1.2.2 Untargeted Metabolomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 UNTARGETED METABOLOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 UNTARGETED METABOLOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Untargeted Metabolomics Product Life Cycle
3.3 Global Untargeted Metabolomics Revenue Market Share by Company (2020-2025)
3.4 Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Untargeted Metabolomics Market Competitive Situation and Trends
3.6.1 Untargeted Metabolomics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Untargeted Metabolomics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 UNTARGETED METABOLOMICS VALUE CHAIN ANALYSIS
4.1 Untargeted Metabolomics Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF UNTARGETED METABOLOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Untargeted Metabolomics Market Porter's Five Forces Analysis
6 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Untargeted Metabolomics Market by Type (2020-2025)
6.3 Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
7 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Untargeted Metabolomics Market Size (M USD) by Application (2020-2025)
7.3 Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
8 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY REGION
8.1 Global Untargeted Metabolomics Market Size by Region
8.1.1 Global Untargeted Metabolomics Market Size by Region
8.1.2 Global Untargeted Metabolomics Market Size Market Share by Region
8.2 North America
8.2.1 North America Untargeted Metabolomics Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Untargeted Metabolomics Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Untargeted Metabolomics Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Untargeted Metabolomics Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Untargeted Metabolomics Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Dynamics Inc (Creative Proteomics)
9.1.1 Creative Dynamics Inc (Creative Proteomics) Basic Information
9.1.2 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Overview
9.1.3 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Market Performance
9.1.4 Creative Dynamics Inc (Creative Proteomics) SWOT Analysis
9.1.5 Creative Dynamics Inc (Creative Proteomics) Business Overview
9.1.6 Creative Dynamics Inc (Creative Proteomics) Recent Developments
9.2 Metabolon
9.2.1 Metabolon Basic Information
9.2.2 Metabolon Untargeted Metabolomics Product Overview
9.2.3 Metabolon Untargeted Metabolomics Product Market Performance
9.2.4 Metabolon SWOT Analysis
9.2.5 Metabolon Business Overview
9.2.6 Metabolon Recent Developments
9.3 Alfa Chemistry
9.3.1 Alfa Chemistry Basic Information
9.3.2 Alfa Chemistry Untargeted Metabolomics Product Overview
9.3.3 Alfa Chemistry Untargeted Metabolomics Product Market Performance
9.3.4 Alfa Chemistry SWOT Analysis
9.3.5 Alfa Chemistry Business Overview
9.3.6 Alfa Chemistry Recent Developments
9.4 Novelgene Technologies
9.4.1 Novelgene Technologies Basic Information
9.4.2 Novelgene Technologies Untargeted Metabolomics Product Overview
9.4.3 Novelgene Technologies Untargeted Metabolomics Product Market Performance
9.4.4 Novelgene Technologies Business Overview
9.4.5 Novelgene Technologies Recent Developments
9.5 MtoZ-Biolabs Inc.
9.5.1 MtoZ-Biolabs Inc. Basic Information
9.5.2 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Overview
9.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Market Performance
9.5.4 MtoZ-Biolabs Inc. Business Overview
9.5.5 MtoZ-Biolabs Inc. Recent Developments
9.6 CD Genomics
9.6.1 CD Genomics Basic Information
9.6.2 CD Genomics Untargeted Metabolomics Product Overview
9.6.3 CD Genomics Untargeted Metabolomics Product Market Performance
9.6.4 CD Genomics Business Overview
9.6.5 CD Genomics Recent Developments
9.7 Metware Biotechnology Inc (Metware)
9.7.1 Metware Biotechnology Inc (Metware) Basic Information
9.7.2 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Overview
9.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Market Performance
9.7.4 Metware Biotechnology Inc (Metware) Business Overview
9.7.5 Metware Biotechnology Inc (Metware) Recent Developments
9.8 BGI Genomics
9.8.1 BGI Genomics Basic Information
9.8.2 BGI Genomics Untargeted Metabolomics Product Overview
9.8.3 BGI Genomics Untargeted Metabolomics Product Market Performance
9.8.4 BGI Genomics Business Overview
9.8.5 BGI Genomics Recent Developments
9.9 APPLIED PROTEIN TECHNOLOGY
9.9.1 APPLIED PROTEIN TECHNOLOGY Basic Information
9.9.2 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Overview
9.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Market Performance
9.9.4 APPLIED PROTEIN TECHNOLOGY Business Overview
9.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments
9.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
9.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information
9.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Overview
9.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Market Performance
9.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
9.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments
9.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
9.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information
9.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Overview
9.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Market Performance
9.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
9.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments
9.12 Beijing Huayi innovation and BioTechnology Co., Ltd
9.12.1 Beijing Huayi innovation and BioTechnology Co., Ltd Basic Information
9.12.2 Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Overview
9.12.3 Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Market Performance
9.12.4 Beijing Huayi innovation and BioTechnology Co., Ltd Business Overview
9.12.5 Beijing Huayi innovation and BioTechnology Co., Ltd Recent Developments
9.13 Abace Biotechnology
9.13.1 Abace Biotechnology Basic Information
9.13.2 Abace Biotechnology Untargeted Metabolomics Product Overview
9.13.3 Abace Biotechnology Untargeted Metabolomics Product Market Performance
9.13.4 Abace Biotechnology Business Overview
9.13.5 Abace Biotechnology Recent Developments
9.14 Metabo-Profile
9.14.1 Metabo-Profile Basic Information
9.14.2 Metabo-Profile Untargeted Metabolomics Product Overview
9.14.3 Metabo-Profile Untargeted Metabolomics Product Market Performance
9.14.4 Metabo-Profile Business Overview
9.14.5 Metabo-Profile Recent Developments
10 UNTARGETED METABOLOMICS MARKET FORECAST BY REGION
10.1 Global Untargeted Metabolomics Market Size Forecast
10.2 Global Untargeted Metabolomics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Untargeted Metabolomics Market Size Forecast by Country
10.2.3 Asia Pacific Untargeted Metabolomics Market Size Forecast by Region
10.2.4 South America Untargeted Metabolomics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Untargeted Metabolomics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Untargeted Metabolomics Market Forecast by Type (2026-2035)
11.1.1 Global Untargeted Metabolomics Market Size Forecast by Type (2026-2035)
11.2 Global Untargeted Metabolomics Market Forecast by Application (2026-2035)
11.2.1 Global Untargeted Metabolomics Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Untargeted Metabolomics
1.2 Key Market Segments
1.2.1 Untargeted Metabolomics Segment by Type
1.2.2 Untargeted Metabolomics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 UNTARGETED METABOLOMICS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 UNTARGETED METABOLOMICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Untargeted Metabolomics Product Life Cycle
3.3 Global Untargeted Metabolomics Revenue Market Share by Company (2020-2025)
3.4 Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Untargeted Metabolomics Market Competitive Situation and Trends
3.6.1 Untargeted Metabolomics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Untargeted Metabolomics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 UNTARGETED METABOLOMICS VALUE CHAIN ANALYSIS
4.1 Untargeted Metabolomics Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF UNTARGETED METABOLOMICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Untargeted Metabolomics Market Porter's Five Forces Analysis
6 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Untargeted Metabolomics Market by Type (2020-2025)
6.3 Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
7 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Untargeted Metabolomics Market Size (M USD) by Application (2020-2025)
7.3 Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
8 UNTARGETED METABOLOMICS MARKET SEGMENTATION BY REGION
8.1 Global Untargeted Metabolomics Market Size by Region
8.1.1 Global Untargeted Metabolomics Market Size by Region
8.1.2 Global Untargeted Metabolomics Market Size Market Share by Region
8.2 North America
8.2.1 North America Untargeted Metabolomics Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Untargeted Metabolomics Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Untargeted Metabolomics Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Untargeted Metabolomics Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Untargeted Metabolomics Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Creative Dynamics Inc (Creative Proteomics)
9.1.1 Creative Dynamics Inc (Creative Proteomics) Basic Information
9.1.2 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Overview
9.1.3 Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Market Performance
9.1.4 Creative Dynamics Inc (Creative Proteomics) SWOT Analysis
9.1.5 Creative Dynamics Inc (Creative Proteomics) Business Overview
9.1.6 Creative Dynamics Inc (Creative Proteomics) Recent Developments
9.2 Metabolon
9.2.1 Metabolon Basic Information
9.2.2 Metabolon Untargeted Metabolomics Product Overview
9.2.3 Metabolon Untargeted Metabolomics Product Market Performance
9.2.4 Metabolon SWOT Analysis
9.2.5 Metabolon Business Overview
9.2.6 Metabolon Recent Developments
9.3 Alfa Chemistry
9.3.1 Alfa Chemistry Basic Information
9.3.2 Alfa Chemistry Untargeted Metabolomics Product Overview
9.3.3 Alfa Chemistry Untargeted Metabolomics Product Market Performance
9.3.4 Alfa Chemistry SWOT Analysis
9.3.5 Alfa Chemistry Business Overview
9.3.6 Alfa Chemistry Recent Developments
9.4 Novelgene Technologies
9.4.1 Novelgene Technologies Basic Information
9.4.2 Novelgene Technologies Untargeted Metabolomics Product Overview
9.4.3 Novelgene Technologies Untargeted Metabolomics Product Market Performance
9.4.4 Novelgene Technologies Business Overview
9.4.5 Novelgene Technologies Recent Developments
9.5 MtoZ-Biolabs Inc.
9.5.1 MtoZ-Biolabs Inc. Basic Information
9.5.2 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Overview
9.5.3 MtoZ-Biolabs Inc. Untargeted Metabolomics Product Market Performance
9.5.4 MtoZ-Biolabs Inc. Business Overview
9.5.5 MtoZ-Biolabs Inc. Recent Developments
9.6 CD Genomics
9.6.1 CD Genomics Basic Information
9.6.2 CD Genomics Untargeted Metabolomics Product Overview
9.6.3 CD Genomics Untargeted Metabolomics Product Market Performance
9.6.4 CD Genomics Business Overview
9.6.5 CD Genomics Recent Developments
9.7 Metware Biotechnology Inc (Metware)
9.7.1 Metware Biotechnology Inc (Metware) Basic Information
9.7.2 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Overview
9.7.3 Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Market Performance
9.7.4 Metware Biotechnology Inc (Metware) Business Overview
9.7.5 Metware Biotechnology Inc (Metware) Recent Developments
9.8 BGI Genomics
9.8.1 BGI Genomics Basic Information
9.8.2 BGI Genomics Untargeted Metabolomics Product Overview
9.8.3 BGI Genomics Untargeted Metabolomics Product Market Performance
9.8.4 BGI Genomics Business Overview
9.8.5 BGI Genomics Recent Developments
9.9 APPLIED PROTEIN TECHNOLOGY
9.9.1 APPLIED PROTEIN TECHNOLOGY Basic Information
9.9.2 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Overview
9.9.3 APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Market Performance
9.9.4 APPLIED PROTEIN TECHNOLOGY Business Overview
9.9.5 APPLIED PROTEIN TECHNOLOGY Recent Developments
9.10 Suzhou PANOMIX Biomedical Tech Co.,Ltd
9.10.1 Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information
9.10.2 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Overview
9.10.3 Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Market Performance
9.10.4 Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
9.10.5 Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments
9.11 OBiO Technology ( Shanghai ) Corp.,Ltd.
9.11.1 OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information
9.11.2 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Overview
9.11.3 OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Market Performance
9.11.4 OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
9.11.5 OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments
9.12 Beijing Huayi innovation and BioTechnology Co., Ltd
9.12.1 Beijing Huayi innovation and BioTechnology Co., Ltd Basic Information
9.12.2 Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Overview
9.12.3 Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Market Performance
9.12.4 Beijing Huayi innovation and BioTechnology Co., Ltd Business Overview
9.12.5 Beijing Huayi innovation and BioTechnology Co., Ltd Recent Developments
9.13 Abace Biotechnology
9.13.1 Abace Biotechnology Basic Information
9.13.2 Abace Biotechnology Untargeted Metabolomics Product Overview
9.13.3 Abace Biotechnology Untargeted Metabolomics Product Market Performance
9.13.4 Abace Biotechnology Business Overview
9.13.5 Abace Biotechnology Recent Developments
9.14 Metabo-Profile
9.14.1 Metabo-Profile Basic Information
9.14.2 Metabo-Profile Untargeted Metabolomics Product Overview
9.14.3 Metabo-Profile Untargeted Metabolomics Product Market Performance
9.14.4 Metabo-Profile Business Overview
9.14.5 Metabo-Profile Recent Developments
10 UNTARGETED METABOLOMICS MARKET FORECAST BY REGION
10.1 Global Untargeted Metabolomics Market Size Forecast
10.2 Global Untargeted Metabolomics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Untargeted Metabolomics Market Size Forecast by Country
10.2.3 Asia Pacific Untargeted Metabolomics Market Size Forecast by Region
10.2.4 South America Untargeted Metabolomics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Untargeted Metabolomics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Untargeted Metabolomics Market Forecast by Type (2026-2035)
11.1.1 Global Untargeted Metabolomics Market Size Forecast by Type (2026-2035)
11.2 Global Untargeted Metabolomics Market Forecast by Application (2026-2035)
11.2.1 Global Untargeted Metabolomics Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Untargeted Metabolomics Market Size by Type (M USD)
Table 4. Global Untargeted Metabolomics Market Size by Application
Table 5. Untargeted Metabolomics Market Size Comparison by Region (M USD)
Table 6. Global Untargeted Metabolomics Revenue (M USD) by Company (2020-2025)
Table 7. Global Untargeted Metabolomics Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Untargeted Metabolomics as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Untargeted Metabolomics Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Untargeted Metabolomics Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Untargeted Metabolomics Market Size by Type (M USD)
Table 22. Global Untargeted Metabolomics Market Size (M USD) by Type (2020-2025)
Table 23. Global Untargeted Metabolomics Market Share by Type (2020-2025)
Table 24. Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
Table 25. Global Untargeted Metabolomics Market Size by Application
Table 26. Global Untargeted Metabolomics Market Size by Application (2020-2025) & (M USD)
Table 27. Global Untargeted Metabolomics Market Share by Application (2020-2025)
Table 28. Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
Table 29. Global Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 30. Global Untargeted Metabolomics Market Size Market Share by Region (2020-2025)
Table 31. North America Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 34. South America Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 36. Creative Dynamics Inc (Creative Proteomics) Basic Information
Table 37. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Overview
Table 38. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Creative Dynamics Inc (Creative Proteomics) SWOT Analysis
Table 40. Creative Dynamics Inc (Creative Proteomics) Business Overview
Table 41. Creative Dynamics Inc (Creative Proteomics) Recent Developments
Table 42. Metabolon Basic Information
Table 43. Metabolon Untargeted Metabolomics Product Overview
Table 44. Metabolon Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Metabolon SWOT Analysis
Table 46. Metabolon Business Overview
Table 47. Metabolon Recent Developments
Table 48. Alfa Chemistry Basic Information
Table 49. Alfa Chemistry Untargeted Metabolomics Product Overview
Table 50. Alfa Chemistry Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Alfa Chemistry SWOT Analysis
Table 52. Alfa Chemistry Business Overview
Table 53. Alfa Chemistry Recent Developments
Table 54. Novelgene Technologies Basic Information
Table 55. Novelgene Technologies Untargeted Metabolomics Product Overview
Table 56. Novelgene Technologies Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Novelgene Technologies Business Overview
Table 58. Novelgene Technologies Recent Developments
Table 59. MtoZ-Biolabs Inc. Basic Information
Table 60. MtoZ-Biolabs Inc. Untargeted Metabolomics Product Overview
Table 61. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 62. MtoZ-Biolabs Inc. Business Overview
Table 63. MtoZ-Biolabs Inc. Recent Developments
Table 64. CD Genomics Basic Information
Table 65. CD Genomics Untargeted Metabolomics Product Overview
Table 66. CD Genomics Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 67. CD Genomics Business Overview
Table 68. CD Genomics Recent Developments
Table 69. Metware Biotechnology Inc (Metware) Basic Information
Table 70. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Overview
Table 71. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Metware Biotechnology Inc (Metware) Business Overview
Table 73. Metware Biotechnology Inc (Metware) Recent Developments
Table 74. BGI Genomics Basic Information
Table 75. BGI Genomics Untargeted Metabolomics Product Overview
Table 76. BGI Genomics Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 77. BGI Genomics Business Overview
Table 78. BGI Genomics Recent Developments
Table 79. APPLIED PROTEIN TECHNOLOGY Basic Information
Table 80. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Overview
Table 81. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 82. APPLIED PROTEIN TECHNOLOGY Business Overview
Table 83. APPLIED PROTEIN TECHNOLOGY Recent Developments
Table 84. Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information
Table 85. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Overview
Table 86. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
Table 88. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments
Table 89. OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information
Table 90. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Overview
Table 91. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 92. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 93. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments
Table 94. Beijing Huayi innovation and BioTechnology Co., Ltd Basic Information
Table 95. Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Overview
Table 96. Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Beijing Huayi innovation and BioTechnology Co., Ltd Business Overview
Table 98. Beijing Huayi innovation and BioTechnology Co., Ltd Recent Developments
Table 99. Abace Biotechnology Basic Information
Table 100. Abace Biotechnology Untargeted Metabolomics Product Overview
Table 101. Abace Biotechnology Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Abace Biotechnology Business Overview
Table 103. Abace Biotechnology Recent Developments
Table 104. Metabo-Profile Basic Information
Table 105. Metabo-Profile Untargeted Metabolomics Product Overview
Table 106. Metabo-Profile Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Metabo-Profile Business Overview
Table 108. Metabo-Profile Recent Developments
Table 109. Global Untargeted Metabolomics Market Size Forecast by Region (2026-2035) & (M USD)
Table 110. North America Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Europe Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Asia Pacific Untargeted Metabolomics Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Middle East and Africa Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Global Untargeted Metabolomics Market Size Forecast by Type (2026-2035) & (M USD)
Table 116. Global Untargeted Metabolomics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Untargeted Metabolomics Market Size by Type (M USD)
Table 4. Global Untargeted Metabolomics Market Size by Application
Table 5. Untargeted Metabolomics Market Size Comparison by Region (M USD)
Table 6. Global Untargeted Metabolomics Revenue (M USD) by Company (2020-2025)
Table 7. Global Untargeted Metabolomics Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Untargeted Metabolomics as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Untargeted Metabolomics Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Untargeted Metabolomics Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Untargeted Metabolomics Market Size by Type (M USD)
Table 22. Global Untargeted Metabolomics Market Size (M USD) by Type (2020-2025)
Table 23. Global Untargeted Metabolomics Market Share by Type (2020-2025)
Table 24. Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
Table 25. Global Untargeted Metabolomics Market Size by Application
Table 26. Global Untargeted Metabolomics Market Size by Application (2020-2025) & (M USD)
Table 27. Global Untargeted Metabolomics Market Share by Application (2020-2025)
Table 28. Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
Table 29. Global Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 30. Global Untargeted Metabolomics Market Size Market Share by Region (2020-2025)
Table 31. North America Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 34. South America Untargeted Metabolomics Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Untargeted Metabolomics Market Size by Region (2020-2025) & (M USD)
Table 36. Creative Dynamics Inc (Creative Proteomics) Basic Information
Table 37. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Product Overview
Table 38. Creative Dynamics Inc (Creative Proteomics) Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Creative Dynamics Inc (Creative Proteomics) SWOT Analysis
Table 40. Creative Dynamics Inc (Creative Proteomics) Business Overview
Table 41. Creative Dynamics Inc (Creative Proteomics) Recent Developments
Table 42. Metabolon Basic Information
Table 43. Metabolon Untargeted Metabolomics Product Overview
Table 44. Metabolon Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Metabolon SWOT Analysis
Table 46. Metabolon Business Overview
Table 47. Metabolon Recent Developments
Table 48. Alfa Chemistry Basic Information
Table 49. Alfa Chemistry Untargeted Metabolomics Product Overview
Table 50. Alfa Chemistry Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Alfa Chemistry SWOT Analysis
Table 52. Alfa Chemistry Business Overview
Table 53. Alfa Chemistry Recent Developments
Table 54. Novelgene Technologies Basic Information
Table 55. Novelgene Technologies Untargeted Metabolomics Product Overview
Table 56. Novelgene Technologies Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Novelgene Technologies Business Overview
Table 58. Novelgene Technologies Recent Developments
Table 59. MtoZ-Biolabs Inc. Basic Information
Table 60. MtoZ-Biolabs Inc. Untargeted Metabolomics Product Overview
Table 61. MtoZ-Biolabs Inc. Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 62. MtoZ-Biolabs Inc. Business Overview
Table 63. MtoZ-Biolabs Inc. Recent Developments
Table 64. CD Genomics Basic Information
Table 65. CD Genomics Untargeted Metabolomics Product Overview
Table 66. CD Genomics Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 67. CD Genomics Business Overview
Table 68. CD Genomics Recent Developments
Table 69. Metware Biotechnology Inc (Metware) Basic Information
Table 70. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Product Overview
Table 71. Metware Biotechnology Inc (Metware) Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 72. Metware Biotechnology Inc (Metware) Business Overview
Table 73. Metware Biotechnology Inc (Metware) Recent Developments
Table 74. BGI Genomics Basic Information
Table 75. BGI Genomics Untargeted Metabolomics Product Overview
Table 76. BGI Genomics Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 77. BGI Genomics Business Overview
Table 78. BGI Genomics Recent Developments
Table 79. APPLIED PROTEIN TECHNOLOGY Basic Information
Table 80. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Product Overview
Table 81. APPLIED PROTEIN TECHNOLOGY Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 82. APPLIED PROTEIN TECHNOLOGY Business Overview
Table 83. APPLIED PROTEIN TECHNOLOGY Recent Developments
Table 84. Suzhou PANOMIX Biomedical Tech Co.,Ltd Basic Information
Table 85. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Product Overview
Table 86. Suzhou PANOMIX Biomedical Tech Co.,Ltd Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Suzhou PANOMIX Biomedical Tech Co.,Ltd Business Overview
Table 88. Suzhou PANOMIX Biomedical Tech Co.,Ltd Recent Developments
Table 89. OBiO Technology ( Shanghai ) Corp.,Ltd. Basic Information
Table 90. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Product Overview
Table 91. OBiO Technology ( Shanghai ) Corp.,Ltd. Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 92. OBiO Technology ( Shanghai ) Corp.,Ltd. Business Overview
Table 93. OBiO Technology ( Shanghai ) Corp.,Ltd. Recent Developments
Table 94. Beijing Huayi innovation and BioTechnology Co., Ltd Basic Information
Table 95. Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Product Overview
Table 96. Beijing Huayi innovation and BioTechnology Co., Ltd Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Beijing Huayi innovation and BioTechnology Co., Ltd Business Overview
Table 98. Beijing Huayi innovation and BioTechnology Co., Ltd Recent Developments
Table 99. Abace Biotechnology Basic Information
Table 100. Abace Biotechnology Untargeted Metabolomics Product Overview
Table 101. Abace Biotechnology Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Abace Biotechnology Business Overview
Table 103. Abace Biotechnology Recent Developments
Table 104. Metabo-Profile Basic Information
Table 105. Metabo-Profile Untargeted Metabolomics Product Overview
Table 106. Metabo-Profile Untargeted Metabolomics Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Metabo-Profile Business Overview
Table 108. Metabo-Profile Recent Developments
Table 109. Global Untargeted Metabolomics Market Size Forecast by Region (2026-2035) & (M USD)
Table 110. North America Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Europe Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 112. Asia Pacific Untargeted Metabolomics Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 114. Middle East and Africa Untargeted Metabolomics Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Global Untargeted Metabolomics Market Size Forecast by Type (2026-2035) & (M USD)
Table 116. Global Untargeted Metabolomics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Untargeted Metabolomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Untargeted Metabolomics Market Size (M USD), 2025-2035
Figure 5. Global Untargeted Metabolomics Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Untargeted Metabolomics Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Untargeted Metabolomics Product Life Cycle
Figure 12. Global Untargeted Metabolomics Revenue Share by Company in 2025
Figure 13. Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Untargeted Metabolomics Revenue in 2025
Figure 15. Value Chain Map of Untargeted Metabolomics
Figure 16. Global Untargeted Metabolomics Market PEST Analysis
Figure 17. Global Untargeted Metabolomics Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Untargeted Metabolomics Market Share by Type
Figure 20. Market Share of Untargeted Metabolomics by Type (2020-2025)
Figure 21. Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Untargeted Metabolomics Market Share by Application
Figure 24. Global Untargeted Metabolomics Market Share by Application (2020-2025)
Figure 25. Global Untargeted Metabolomics Market Share by Application in 2024
Figure 26. Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Untargeted Metabolomics Market Size Market Share by Region (2020-2025)
Figure 28. North America Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Untargeted Metabolomics Market Size Market Share by Country in 2024
Figure 30. U.S. Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Untargeted Metabolomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Untargeted Metabolomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Untargeted Metabolomics Market Share by Country in 2024
Figure 35. Germany Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Untargeted Metabolomics Market Size Market Share by Region in 2024
Figure 42. China Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 48. South America Untargeted Metabolomics Market Size Market Share by Country in 2024
Figure 49. Brazil Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Untargeted Metabolomics Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Untargeted Metabolomics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Untargeted Metabolomics Market Share Forecast by Type (2026-2035)
Figure 61. Global Untargeted Metabolomics Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Untargeted Metabolomics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Untargeted Metabolomics Market Size (M USD), 2025-2035
Figure 5. Global Untargeted Metabolomics Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Untargeted Metabolomics Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Untargeted Metabolomics Product Life Cycle
Figure 12. Global Untargeted Metabolomics Revenue Share by Company in 2025
Figure 13. Untargeted Metabolomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Untargeted Metabolomics Revenue in 2025
Figure 15. Value Chain Map of Untargeted Metabolomics
Figure 16. Global Untargeted Metabolomics Market PEST Analysis
Figure 17. Global Untargeted Metabolomics Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Untargeted Metabolomics Market Share by Type
Figure 20. Market Share of Untargeted Metabolomics by Type (2020-2025)
Figure 21. Global Untargeted Metabolomics Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Untargeted Metabolomics Market Share by Application
Figure 24. Global Untargeted Metabolomics Market Share by Application (2020-2025)
Figure 25. Global Untargeted Metabolomics Market Share by Application in 2024
Figure 26. Global Untargeted Metabolomics Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Untargeted Metabolomics Market Size Market Share by Region (2020-2025)
Figure 28. North America Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Untargeted Metabolomics Market Size Market Share by Country in 2024
Figure 30. U.S. Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Untargeted Metabolomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Untargeted Metabolomics Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Untargeted Metabolomics Market Share by Country in 2024
Figure 35. Germany Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Untargeted Metabolomics Market Size Market Share by Region in 2024
Figure 42. China Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 48. South America Untargeted Metabolomics Market Size Market Share by Country in 2024
Figure 49. Brazil Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Untargeted Metabolomics Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Untargeted Metabolomics Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Untargeted Metabolomics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Untargeted Metabolomics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Untargeted Metabolomics Market Share Forecast by Type (2026-2035)
Figure 61. Global Untargeted Metabolomics Market Share Forecast by Application (2026-2035)
